Johnson & Johnson, which set aside $2.5 billion last year to resolve claims that 8,000 of its artificial hips were defective, faces a new round of lawsuits over another line of hip implants blamed for poisoning patients.
Bloomberg
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
Subtle Medical’s Imaging Processor Cleared by FDA
The software is helpful for patients who have difficulty remaining still for long periods.
FDA Approves Descovy as HIV Prevention Treatment
Gilead said that Descovy offers “statistically significant improvements in renal and bone safety” compared to Truvada.
FDAnews Device Daily Bulletin
J&J's Pinnacle Hips Face First Trial on Poisoned Patients
Sept. 3, 2014
